Ramsay Pharmacy completes transition to Symbion as primary wholesaler

Ramsay Pharmacy has successfully transitioned to Symbion as its primary pharmaceutical wholesaler, marking a significant milestone in strengthening its national supply chain. 

The change follows a comprehensive request for a proposal process launched in November 2023 to ensure Ramsay’s supply chain continues to meet growing operational and patient care needs across its network of over 100 hospital dispensaries and franchise community pharmacy network. 

Following detailed evaluation, Symbion was selected based on enhanced service capabilities, competitive pricing, and strong alignment with Ramsay Pharmacy’s long-term strategic objectives. 

Ramsay Pharmacy CEO Michelle Lynch said the completed transition supports Ramsay’s commitment to delivering exceptional pharmacy services and continually evolving to meet the needs of patients and partners. 

“Completing our transition to Symbion as our primary wholesaler strengthens our supply chain, enhances service capability and positions our pharmacy network for sustainable growth.” 

Symbion, one of Australia’s largest healthcare wholesalers, now supplies pharmaceuticals, general medicines and retail merchandise to Ramsay’s hospitals, dispensaries and franchise community pharmacy sites nationwide. 

“By partnering with Symbion and their national reach and proven expertise, we can better support our expanding pharmacy operations while maintaining the high standards of care our patients expect,” Ms Lynch said. 

“This has been a coordinated effort across our procurement, finance, supply chain, systems and operational teams, and I thank everyone involved for ensuring a smooth transition.” 

Ms Lynch said the change builds a stronger foundation for future innovation and connected care. 

“With Symbion as our partner, Ramsay Pharmacy is well positioned to grow, adapt and deliver even greater value to the communities we serve.”